Peritoneal dialysis is feasible as a bridge to combined liver-kidney transplant

Ruth Ellen Jones, Yun Liang, Malcolm MacConmara, Christine Hwang, Ramesh Saxena

Research output: Contribution to journalArticle

Abstract

Patients with combined liver and kidney failure may remain on dialysis for years while awaiting simultaneous liver-kidney transplantation (SLKT). The role of peritoneal dialysis (PD) in patients with advanced liver and kidney failure awaiting SLKT remains to be defined. We present our single-institution experience with PD in cirrhotics, 3 of whom went on to receive successful SLKT. Patients initiated in our PD program between 2006 and 2016 who had both liver and kidney failure were identified. Medical and dialysis records were reviewed retrospectively. Outcomes included mortality, transplantation status, hospitalizations, need for large-volume paracentesis (LVP), peritonitis rates, PD treatment longevity, and albumin level. Twelve patients with combined liver and kidney failure were treated in our PD program. No patients died and 3 patients received SLKT. Four patients remain listed for transplantation. There was no need for LVP after initiating dialysis. The rate of peritonitis was 0.2 events per patient per year, most commonly due to coagulase-negative Staphylococcus. Our data illustrate that PD is a viable bridging therapy for patients with liver and kidney failure who await SLKT.

Original languageEnglish (US)
Pages (from-to)63-65
Number of pages3
JournalPeritoneal Dialysis International
Volume38
Issue number1
DOIs
StatePublished - Jan 1 2018

Fingerprint

Peritoneal Dialysis
Transplants
Kidney
Liver Failure
Liver
Liver Transplantation
Kidney Transplantation
Renal Insufficiency
Paracentesis
Dialysis
Peritonitis
Transplantation
Coagulase
Staphylococcus
Medical Records
Albumins
Hospitalization
Mortality
Therapeutics

Keywords

  • Ascites
  • Cirrhosis
  • Peritoneal dialysis
  • Simultaneous liver-kidney transplantation

ASJC Scopus subject areas

  • Nephrology

Cite this

Peritoneal dialysis is feasible as a bridge to combined liver-kidney transplant. / Jones, Ruth Ellen; Liang, Yun; MacConmara, Malcolm; Hwang, Christine; Saxena, Ramesh.

In: Peritoneal Dialysis International, Vol. 38, No. 1, 01.01.2018, p. 63-65.

Research output: Contribution to journalArticle

@article{801ea24df4f44bbf86e0c7e6e7641dce,
title = "Peritoneal dialysis is feasible as a bridge to combined liver-kidney transplant",
abstract = "Patients with combined liver and kidney failure may remain on dialysis for years while awaiting simultaneous liver-kidney transplantation (SLKT). The role of peritoneal dialysis (PD) in patients with advanced liver and kidney failure awaiting SLKT remains to be defined. We present our single-institution experience with PD in cirrhotics, 3 of whom went on to receive successful SLKT. Patients initiated in our PD program between 2006 and 2016 who had both liver and kidney failure were identified. Medical and dialysis records were reviewed retrospectively. Outcomes included mortality, transplantation status, hospitalizations, need for large-volume paracentesis (LVP), peritonitis rates, PD treatment longevity, and albumin level. Twelve patients with combined liver and kidney failure were treated in our PD program. No patients died and 3 patients received SLKT. Four patients remain listed for transplantation. There was no need for LVP after initiating dialysis. The rate of peritonitis was 0.2 events per patient per year, most commonly due to coagulase-negative Staphylococcus. Our data illustrate that PD is a viable bridging therapy for patients with liver and kidney failure who await SLKT.",
keywords = "Ascites, Cirrhosis, Peritoneal dialysis, Simultaneous liver-kidney transplantation",
author = "Jones, {Ruth Ellen} and Yun Liang and Malcolm MacConmara and Christine Hwang and Ramesh Saxena",
year = "2018",
month = "1",
day = "1",
doi = "10.3747/pdi.2017.00124",
language = "English (US)",
volume = "38",
pages = "63--65",
journal = "Peritoneal Dialysis International",
issn = "0896-8608",
publisher = "Multimed Inc.",
number = "1",

}

TY - JOUR

T1 - Peritoneal dialysis is feasible as a bridge to combined liver-kidney transplant

AU - Jones, Ruth Ellen

AU - Liang, Yun

AU - MacConmara, Malcolm

AU - Hwang, Christine

AU - Saxena, Ramesh

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Patients with combined liver and kidney failure may remain on dialysis for years while awaiting simultaneous liver-kidney transplantation (SLKT). The role of peritoneal dialysis (PD) in patients with advanced liver and kidney failure awaiting SLKT remains to be defined. We present our single-institution experience with PD in cirrhotics, 3 of whom went on to receive successful SLKT. Patients initiated in our PD program between 2006 and 2016 who had both liver and kidney failure were identified. Medical and dialysis records were reviewed retrospectively. Outcomes included mortality, transplantation status, hospitalizations, need for large-volume paracentesis (LVP), peritonitis rates, PD treatment longevity, and albumin level. Twelve patients with combined liver and kidney failure were treated in our PD program. No patients died and 3 patients received SLKT. Four patients remain listed for transplantation. There was no need for LVP after initiating dialysis. The rate of peritonitis was 0.2 events per patient per year, most commonly due to coagulase-negative Staphylococcus. Our data illustrate that PD is a viable bridging therapy for patients with liver and kidney failure who await SLKT.

AB - Patients with combined liver and kidney failure may remain on dialysis for years while awaiting simultaneous liver-kidney transplantation (SLKT). The role of peritoneal dialysis (PD) in patients with advanced liver and kidney failure awaiting SLKT remains to be defined. We present our single-institution experience with PD in cirrhotics, 3 of whom went on to receive successful SLKT. Patients initiated in our PD program between 2006 and 2016 who had both liver and kidney failure were identified. Medical and dialysis records were reviewed retrospectively. Outcomes included mortality, transplantation status, hospitalizations, need for large-volume paracentesis (LVP), peritonitis rates, PD treatment longevity, and albumin level. Twelve patients with combined liver and kidney failure were treated in our PD program. No patients died and 3 patients received SLKT. Four patients remain listed for transplantation. There was no need for LVP after initiating dialysis. The rate of peritonitis was 0.2 events per patient per year, most commonly due to coagulase-negative Staphylococcus. Our data illustrate that PD is a viable bridging therapy for patients with liver and kidney failure who await SLKT.

KW - Ascites

KW - Cirrhosis

KW - Peritoneal dialysis

KW - Simultaneous liver-kidney transplantation

UR - http://www.scopus.com/inward/record.url?scp=85041590314&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85041590314&partnerID=8YFLogxK

U2 - 10.3747/pdi.2017.00124

DO - 10.3747/pdi.2017.00124

M3 - Article

C2 - 29311195

AN - SCOPUS:85041590314

VL - 38

SP - 63

EP - 65

JO - Peritoneal Dialysis International

JF - Peritoneal Dialysis International

SN - 0896-8608

IS - 1

ER -